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Abstract
Background: While some medical associations provide guidelines for the implant-
prosthetic rehabilitation of head and neck cancer patients, the circulation and imple-
mentation in the everyday routine of practicing dentists remain unknown.
Purpose: To analyze patterns of care for the prosthetic rehabilitation of head and
neck cancer patients after radiotherapy in German speaking countries.
Materials and methods: An online survey consisting of 34 questions separated into
three sections, (a) general inquiries, (b) treatment concepts, and (c) patient cases, was
forwarded to university hospital departments for Prosthetic Dentistry and Oral and
Maxillofacial Surgery, and members of different medical associations. Statistical dif-
ferences between groups were analyzed using chi-squared test (P < .05).
Results: From May to October 2019, 118 participants completed the survey. The
majority practiced in university hospitals, had more than 5 years of work experience,
and reported to be involved in <10 post radiation prosthetic rehabilitation cases per
year. Rehabilitation protocols involving dental implants were implemented by oral/
oral- and maxillofacial surgeons and prosthetic dentists, while general dentists
favored implant-free solutions. Xerostomia was recognized as a common problem for
a successful prosthetic rehabilitation. The subsequent treatment choice with either
fixed dental prostheses or removable dentures was divided among participants.
Conclusions: As treatment planning differed with regard to the participants' field of
expertise and work environment, and most practitioners only handle a low number of
cases, patients might benefit from centralization in larger institutes with a multi-
disciplinary structure. A high agreement between the practitioners' treatment
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concepts and the current state of research was observed. While the choice between
a mucosa- or tooth-supported, and an implant-supported restoration depends on
numerous individual factors, guidelines derived from longitudinal studies would
enhance evidence-based treatment in this field.
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1 | INTRODUCTION
The term head and neck cancer describes an array of malignancies in
this region ranging from neoplasia of the paranasal sinuses to oral,
pharyngeal, or laryngeal carcinoma. Worldwide, head and neck cancer
accounts for more than 650 000 cases and 330 000 deaths per year.1
The average age at diagnosis ranges between 55 and 65 years, with
males being affected twice as often as females.2 Treatment plans for
the individual patient vary, as they are dependent on numerous fac-
tors, such as the location of the primary tumor, cancer staging, and
the patient's general health and age. State of the art treatment is
radio(chemo)therapy and/or surgery, with common treatment side
effects including mucositis, salivary gland dysfunctions causing
xerostomia and osteoradionecrosis (ORN) of the jaw.3-6 Whereas
pulpal tissue can be directly damaged by radiation, the sequelae of
xerostomia, such as a decrease in pH, a reduced buffering capacity,
and an increased viscosity of the saliva, can lead to radiation caries,
characterized by an expedited tooth decay.6-8
While cancer treatment is routinely conducted in a multidisciplinary
setting, with specialist physicians such as ENT/head and neck cancer sur-
geons and oral- and maxillofacial surgeons performing the surgery, oncol-
ogists or radiation oncologists administering chemotherapy, radiation
oncologists delivering exact dosages to the target volume and dentists
carrying out a perioperative dental evaluation, the subsequent rehabilita-
tion of head and neck cancer patients often involves just one dentist.
The question arises, in how far individual dentists are capable of fulfilling
this often highly challenging task. There are numerous factors complicat-
ing the perioperative dental evaluation and care, such as an increased
number of missing teeth after multiple extractions to reduce interven-
tions postradiation and hereby the risk of developing an
osteoradionecrosis,4 or scar tissue impairing mouth opening. In addition,
a trismus may limit the dentist's treatment options, as the patient's ability
to brush his teeth or incorporate a removable denture can be severely
restricted. The primary surgery can furthermore entail extensive defects
that call for a prosthetic reconstruction employing obturator prostheses
in cases where reconstructive surgery is not an option. To replace miss-
ing teeth, a dentist can choose between three options: a removable den-
ture, a fixed dental prosthesis, or implantation.
In patients presenting with a compromised bone and mucosa struc-
ture, xerostomia, impaired orofacial motor functions, an impaired denture
foundation or anatomical changes after resective and reconstructive sur-
gical procedures, implants can be indicated.9 An increase of abutments
by implantation can improve the masticatory function and fixation of a
denture, while reducing the occurrence of pressure marks10 and a subse-
quent development of ORN. Improved esthetics and phonetics achieved
by the oral rehabilitation with implants can have a positive impact on the
patients' psychological and social status. Systematic reviews and meta-
analyses have shown promising long-term survival rates, as implant sur-
vival in nonirradiated and irradiated native bone may be comparable.11-13
On the other hand, removable or fixed dental prostheses can repre-
sent the treatment of choice for patients with an increased risk of
implant loss and the development of ORN, or a high risk for the occur-
rence of a second primary carcinoma.9 In head and neck cancer, second
primary tumors occur frequently, as malignant cell transformations cau-
sed by alcohol, tobacco or HPV are not limited to the primary tumor
site.14 During radiation treatment, implants can increase dosage in the
surrounding tissues through scatter irradiation by up to 25%,15 hereby
raising the risk of developing an ORN. A reduced germ resistance, vas-
cularization, and cell density of irradiation-damaged tissue can impede
the osseous integration and long-term success of the implant
therapy,16,17 with the 5-year implant survival for patients suffering from
a preexisting ORN being reported to be less than 50%.18
Therefore, the advantages of an implant insertion have to be
weighed against the risks of implant failure and the development of
an ORN. In this context, the individual dentist's work environment
(university hospital, medical care center, group private practice, or sin-
gle private practice) and field of expertise (oral surgery/oral- and max-
illofacial surgery, prosthetic dentistry, or general dentistry) might play
a crucial role. While some medical associations, such as the German
association for oral and maxillofacial surgery (DGMKG), provide a
guideline for the implant-prosthetic rehabilitation of head and neck
cancer patients,19 its circulation and implementation in the everyday
routine of practicing dentists remains unknown.
The aim of this multidisciplinary study was to analyze patterns of
care in the prosthetic rehabilitation of head and neck cancer patients
(condition after radiotherapy) in German speaking countries. The
tested hypothesis stated that neither the participants' work environ-
ment nor their field of expertise affect the subsequent treatment.
2 | MATERIALS AND METHODS
The survey “Prosthetic rehabilitation of head and neck cancer patients
after radiotherapy” consisted of 34 questions split into three sections:
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(a) general inquiries, (b) treatment concepts, and (c) patient cases
(Table S1).
To generate the questionnaire, relevant issues and arising ques-
tions of this field were discussed in a multidisciplinary setting of den-
tists, oral- and maxillofacial surgeons, and radiation oncologists.
Questions were then formulated and a test run was performed to check
that all questions were clearly stated and answers were easy to choose
from. After validation within the test group (n = 10 participants), the
questionnaire was adapted and the link to the online survey was for-
warded to all German speaking university hospital departments for
Prosthetic Dentistry and Oral and Maxillofacial Surgery, and members
of the different medical associations (ie, DGZMK, DGMKG, DGPro,
DGOI, BDIZ EDI, BDO). The survey followed the ethics of survey
research by ensuring a maintenance of confidentiality and anonymity
and was previously approved by the ethics committee (19-358 KB).
To analyze potential variations in the treatment of irradiated head
and neck cancer patients across different medical care institutions,
the first section of the survey concentrated on enquiring the work
environment and experience of each participant. While the second
section of the survey addressed different treatment concepts for this
patient cohort, the survey's third section of exemplary patient cases
included free text answers to allow participants to voice individual
prosthetic treatment plans for the exemplary patient John Smith.
Statistical differences between groups were determined using
chi-squared test (P < .05). Data were analyzed with SPSS version 25.0
(IBM, Armonk, New York).
3 | RESULTS
In total, 118 participants completed the online survey between May
and October 2019. As was to be expected in this highly specialized
area, most participants originated from a university hospital back-
ground (55%). On average, 16 (±13) dentists/oral surgeons/oral- and
maxillofacial surgeons were employed in the participants' hospital/
practice. The participant's position at work is depicted in Figure 1,
with the majority (74%) possessing more than 5 years of work experi-
ence. One-third of the participants specified possessing more than
20 years of work experience. The field of expertise of the participants
is shown in Figure 2. When asked how many patients that received
radiotherapy to the head and neck region participants treated with a
prosthetic restoration each year, the majority (72%) indicated treating
up to 10 patients, while 19% provided care for more than 25 patients
each year.
The majority of the participants (73%) indicated that they rou-
tinely enquire the total received radiation dose of the region where
they are planning an implant-prosthetic rehabilitation in head and
neck cancer patients (condition after radiotherapy). Significant differ-
ences in answering this question were observed with regard to the
participants' field of expertise (prosthetic dentistry compared to gen-
eral dentistry and oral/oral- and maxillofacial surgery; P = .004) and
work environment (university hospital compared with a medical care
center/group private practice/single private practice; P = .01), with
only 36% of the general dentists requesting this information, while
83% of participants from a university hospital background and 89% of
oral/oral- and maxillofacial surgeons indicated this as a routine
enquiry prior to implantation in irradiated head and neck cancer
patients. Of those enquiring for the total received radiation dose, 92%
stated that this information influences their treatment concept, with
one-third specifying a total dose of 30 Gy, and the majority (72%) a
total dose of 50 Gy as a critical factor that changes their subsequent
treatment concept. With regard to the treatment modality (Intensity
Modulated Radiation Therapy [IMRT], stereotactic radiotherapy,
tomotherapy, brachytherapy, proton therapy), the majority (66%) indi-
cated no impact on their subsequent treatment. While 54% of the
participants do not perceive a pretreatment with chemotherapy as an
influential factor for their implant-prosthetic treatment concept, the
wide majority (99%) takes the combination of risk factors (smoking,
alcohol, diabetes mellitus, bisphosphonate/antiresorptive therapy)
into account. Furthermore, 92% of the participants stated that the
time lapse from radiotherapy until implant-prosthetic rehabilitation
has an influence on their treatment concept, with 92% indicating
1 year after completion of the radiotherapy being considered as an
adequate time to establish a stable situation for their prosthetic
rehabilitation.
In total, 69% of the participants do not routinely insert implants
in the irradiated region of head and neck cancer patients. The com-
putation of chi-squared test yielded significant differences (P = .006)
between groups based on the participants' field of expertise, with
general dentists refraining from implantation, while a higher number
of prosthetic dentists (26%) and oral/oral- and maxillofacial surgeons
(44%) indicated a routine implant placement. The participants' work

















F IGURE 1 Position at work of the 118 participants (%)
F IGURE 2 Field of expertise of the 118 participants (%)
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from a university hospital background choosing a routine placement
of implants more frequently (46%). Only 36% of the participants
indicated increasing the planned number of implants for irradiated
head and neck cancer patients in comparison to nonirradiated
patients. When asked about a preferred region for their implant-
prosthetic rehabilitation, 46% of the participants stated their plan-
ning to be independent of a region, while 38% indicated the anterior
mandible to be their preferred region. In regard to the best time for
treatment, 86% of the participants waited at least 1 year after com-
pletion of radiotherapy for placing an implant in the irradiated
region. While none indicated the immediate loading of an implant in
the irradiated region as a possible option, two-thirds of the partici-
pants routinely load implants after a period of 6 months. One-third
of the participants stated that they treat irradiated patients with
bone augmentation. Perioperative systemic antibiotics are routinely
prescribed by a wide majority (93%), while only a small number
administered a pretreatment with Vitamin E (8%) or hyperbaric oxy-
gen therapy (5%). When asked about common consequences of the
radiotherapy treatment, 42% to 45% of the participants stated bone
resorption and ORN to appear more frequently, with half of those
indicating a causal link to a prosthetic rehabilitation with removable
prostheses, while 35% did not observe any changes. The wide
majority of participants (94%) stated a reduced or absent saliva pro-
duction after radiotherapy to influence their prosthetic rehabilita-
tion, with 52% of those preferring a subsequent treatment with
fixed dental prostheses. No significant differences between choos-
ing a rehabilitation with removable or fixed dental prostheses were
observed with regard to the participants' field of expertise (P = .4) or
work environment (P = .5).
The third section of the survey enquired about prosthetic treat-
ment concepts neglecting financial aspects for the patient John Smith
(condition after resection of an oropharyngeal carcinoma, adjuvant
radiotherapy with a total dose of 60 Gy and a median dose of 5 Gy on
the maxilla, chemotherapy with Cisplatin weekly 40 mg/kgBW,
64, male). The preferred treatment options for a varying number of
residual teeth in the maxilla and mandible are depicted in Figure 3.
Free text answers included the reference to form a close collaboration
with the treating family dentist and taking into account the patient's
saliva production and maximum mouth opening. While only 4% of the
participants chose ball head anchors, bar constructions, locators, and
telescopes were equally common.
4 | DISCUSSION
The aim of this multidisciplinary study was to analyze patterns of care
in the prosthetic rehabilitation of head and neck cancer patients (con-
dition after radiotherapy) in German speaking countries. The tested
hypothesis stating that neither the participants' work environment
nor their field of expertise affects the subsequent treatment had to be
rejected.
The majority of the participants indicated routinely enquiring for
the total received radiation dose prior to planning an implant-
prosthetic rehabilitation. As significant differences in answering this
question were observed with regard to the participants' field of exper-
tise and work environment, this finding underlines the need to gather
experience and produce prospective data in larger centers and patient
cohorts. A multidisciplinary approach, from the initial planning to the
implementation of treatment, based on a patient's individual constella-
tion of findings and personal wishes, is the prerequisite for therapeu-
tic success20 and has been shown to improve patient treatment and
overall survival in head and neck cancer patients.21
Participants stated radiation thresholds of 30 and 50 Gy as piv-
otal to alter their treatment concept. While animal testing has shown
an explicit dependency between radiation dose and implant
prognosis,22 one retrospective clinical study did not observe an impact
on the radiation dose (<50 or ≥50 Gy) on implant survival.23 Recent
studies do, however, give evidence of a significantly decreased
implant survival, for total radiation doses of 50 Gy,24 55 Gy,12 or
70 Gy.25 Further studies investigating the relationship between total
dose and complication probability, especially with regard to the bone
structure, soft tissue, and the resulting osseointegration of implants,
are warranted. Participants did not perceive the employed treatment
modality as influential on the subsequent implant-prosthetic treat-
ment. IMRT, a technique that allows high doses of radiation to be
applied to the target volume, while sparing adjacent tissues and thus
limiting the damage to vital surrounding organs, represents the cur-
rent gold standard in the treatment of head and neck cancer
patients.26 While one recent study did not observe an influence of
using either 3-D conformal radiotherapy or IMRT on crestal bone loss
and implant survival,27 another investigation with a median follow-up
of 7.4 years could show a preceding radiation using IMRT to result in
superior outcome regarding implant survival.28
While not even half of the participants take a pretreatment with
chemotherapy into account for their implant-prosthetic treatment
concept, the wide majority include risk factors such as smoking, alco-
hol, diabetes mellitus, or bisphosphonate/antiresorptive therapy. One
retrospective clinical study concluded that chemotherapy with cis- or
carboplatin and 5-fluorouracil was not detrimental to the survival and
success of dental implants in the mandible.29 Other studies have,
however, shown a higher prevalence of mucositis after radio-
chemotherapy in comparison with radiotherapy alone,30 just as a neg-
ative effect of cisplatin on the osseointegration of dental implants
was seen in a rabbit model.31 Prior to implantation, individual risk fac-
tors should be taken into account and put into context with the
potential benefits of implant insertion.9
While general dentists refrained from implantation, a small num-
ber of prosthetic dentists and close to half the oral/oral- and maxillo-
facial surgeons indicated a routine placement of implants in the
irradiated region of head and neck cancer patients. Implantation in
this patient cohort seems to be centered in university hospitals, where
a routine placement of implants occurred more frequently. As reviews
have observed promising long-term survival rates for an implantation
in the irradiated jaw,11-13 only one-third of the participants indicated
an increase of their planned number of implants for irradiated head
and neck cancer patients in comparison to nonirradiated patients.
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Half of the participants stated their planning to be independent
of a region, while 38% indicated the mandible anterior region as their
preferred region for implantation. Current literature shows an implant
placement in the mandible to be less prone to failure than in the max-
illa, just as implants in the posterior region carry a higher risk of failure
than those placed in the anterior region.32
Edentulous patient (reduced jaw bone of the maxilla) Edentulous patient (reduced jaw bone of the mandible) 
 
Partially edentulous patient (remaining teeth 6 and 11) Partially edentulous patient (remaining teeth 22 and 27) 
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F IGURE 3 Preferred treatment options for a varying number of residual teeth in the maxilla and mandible
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The majority of participants stated the time lapse from radiother-
apy until implant-prosthetic rehabilitation to hold an influence on their
treatment concept, with 1 year (after completion of radiotherapy)
being considered as an adequate time to establish a stable situation
for an implant-prosthetic rehabilitation. Implant insertion during the
primary tumor surgery can however reduce the number of surgical
procedures, while resulting in high implant survival rates.33,34 Further-
more, implant placement during ablative surgery can lead to functional
benefits, as overdentures retained on implants that were inserted dur-
ing ablative surgery compared to a postponed placement presented a
higher bite force and masticatory performance.35 Although implants
placed in the primary surgery can cause backscattering during radio-
therapy, which can lead to increased doses on the surrounding tissue
and a subsequent loss of the implant, this risk is considered to be
lower than for implants placed in the irradiated bone after radiother-
apy. Immediate implant placement can furthermore shorten the time
period until prosthetic rehabilitation,36 thus improving the patients'
quality of life, and lower the individual costs of implant placement.37
As portrayed in the participants answers, implant placement after
radiotherapy is, however, still more common.38,39 For this setting, a
systematic review has shown periods shorter than 12 months after
radiotherapy to result in a higher risk of implant failure.40 Future
investigations should focus on ascertaining the optimal time period
for the insertion of implants in the oral cavity in regard to
radiotherapy.
While none of the participants chose the immediate loading of an
implant in the irradiated region as a possible option, the majority rou-
tinely load implants after a period of 6 months, as a delayed loading
protocol can enhance the chances of a successful implant
osseointegration, stability and ultimately, an effective dental
rehabilitation.38,39
One-third of the participants stated that they treated irradiated
patients with bone augmentation. As implant survival has been
reported to be significantly lower in grafted bone (8-year survival of
only 54%), even when compared with irradiated residual bone, bone
augmentation after radiotherapy should be avoided.41 The combina-
tion of grafted bone and radiotherapy has been identified as a nega-
tive prognostic factor on implant survival.11,39 In addition, the
placement of dental implants in vascularized grafts at the time of
reconstructive surgery is not recommended, as this led to increased
failure rates and prosthetically unusable or sub-optimally placed
implants.16 In some cases, short dental implants (6-8 mm) might pre-
sent an alternative to advanced and complicated surgical bone
augmentation.42
A perioperative systemic anti-infective is routinely prescribed by
a wide majority, as recommended in guidelines for dental
implantology after radiation therapy.43 Only a small number adminis-
tered a pretreatment with Vitamin E or hyperbaric oxygen therapy.
Though critically discussed in numerous publications, the pre-
treatment with hyperbaric oxygen may not offer any appreciable clini-
cal benefits.44
Bone resorption and ORN were indicated as common conse-
quences of a preceding radiotherapy by nearly half the participants,
with some specifying a causal relationship with removable prostheses.
Using IMRT and a delineation of the mandible as an organ at risk, the
incidence of ORN could be reduced to 0% to 6%.45 A maximum dose
of 70 Gy to the mandible is recommended following dosimetric ana-
lyses, with the volume receiving 50 and 60 Gy being restricted to 62%
and 20% respectively.45,46 In this context, a multidisciplinary approach,
as suggested in a retrospective dosimetry review for oropharyngeal
cancer,47 is recommended by the authors, with radiation oncologists,
oral- and maxillofacial surgeons, and dentists not only jointly planning
preoperative measures and the surgical- and radio-oncologic treatment
of the tumor, but also the subsequent prosthetic rehabilitation. The
delineation of important jaw structures for an ensuing implantation, as
far as considered feasible from an oncologic standpoint, could improve
long-term survival of both the remaining teeth and placed implants, and
in consequence the patient's quality of life.
While the majority of participants stated a reduced or absent
saliva production after radiotherapy to influence their prosthetic reha-
bilitation, the subsequent choice of employing either a fixed dental
prosthesis or a removable denture was divided. In this context, the
administering of amifostine prior to IMRT has been reported to pro-
tect the mucosa and salivary glands from the effects of radiation,48
but is interestingly not widely implemented. The mean doses to con-
tralateral structures should not exceed certain thresholds (parotid:
26 Gy, submandibular gland: 39 Gy). Additionally, the dose to any uni-
nvolved surface of the oral cavity should, if possible, be limited to
30 Gy, as this minimizes damage to the minor salivary glands.49 While
some patients with radiation-induced xerostomia do not tolerate a
rehabilitation with prostheses due to a reduced hold, others benefit
from mucosa-supported dentures, as the high mucosa coverage, for
example seen for maxillary total prostheses, can reduce tissue dehy-
dration. Nevertheless, removable prostheses usually require extensive
follow-up care10; as a result, implant supported restorations could
constitute both a time and cost efficient alternative.
When asked about concrete implant-prosthetic treatment plans
for an exemplary patient (condition after radiotherapy), several trends
were observed. While the rehabilitation with a full denture was con-
sidered an appropriate treatment modality for the edentulous maxilla,
participants preferred an increase of abutments by implantation to
anchor a removable denture in the edentulous mandible. While the
anatomical conditions of the maxilla usually allow for satisfactory
results in the rehabilitation with total prostheses, achieving a suffi-
cient hold of a full denture in the mandible can be demanding or even
unfeasible. When paired with two further aspects, namely the mandi-
bles higher susceptibility to ORN due to is poor vascularization and
high bone density, and the greater success of implant
osseointegration in the irradiated mandible when compared to the
irradiated maxilla,25 the participants' answers can be retraced. For the
rehabilitation of the edentulous mandible, participants primarily chose
a restoration anchored on four implants. While an implant-prosthetic
rehabilitation of head and neck cancer patients with two or four
implant-supported overdentures in the mandible can improve the
patients' quality of life,50 no significant difference between the place-
ment of two or four implants could be observed.51 Overall, implant-
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supported overdentures have been demonstrated to lead to higher
bite forces than conventional prostheses and reduce functional prob-
lems associated with solid foods.35
If the exemplary patient did, however, retain teeth in an optimal
static position, the treatment concepts of the maxilla and mandible
aligned, and a removable denture anchored on telescopes became the
chosen treatment modality. The telescope denture maintained being
the favorite treatment choice for a remaining number of both four and
six teeth, while bridge restorations were primarily chosen as the restora-
tion of choice for single-tooth gaps. With radiation exhibiting long-term
detrimental effects on the natural tooth structure, single-unit implants
might constitute a valid treatment option, as indicated by one-fifth of
the participants. Longitudinal studies examining the long-term survival of
fixed dental prostheses anchored on natural teeth of the irradiated jaw
are warranted, in particular when compared with implant restorations.
The main limitation of this pattern of care analysis is its limited
number of participants, which can affect the representativity of the
collected data. When regarding the work environment and field of
expertise of the participants, it becomes clear that in this highly spe-
cialized field, treatment is primarily provided by university hospitals,
and even there specialized and experienced dentists only treat a lim-
ited number of patients per year. This observation underlines the
importance of raising awareness about possible treatment concepts
and their respective advantages and disadvantages, as the rehabilita-
tion of this patient cohort is far from routine. One further limitation of
this study is constituted by the origin of its respondents, as the survey
was only conducted in German speaking countries. It would be inter-
esting to enquire whether and, if applicable, what differences occur in
the implant-prosthetic treatment of head and neck cancer patients
worldwide. Two, as of today however outdated, surveys conducted in
the United Kingdom observed a wide heterogeneity in the dental and
oral rehabilitation of head and neck cancer patients.52,53 While this
study provides information about the prevalence of different treat-
ment methods and critically evaluates these trends with regard to the
current literature, future studies should concentrate on expanding our
knowledge about the long-term clinical outcome of different implant-
prosthetic treatment plans for head and neck cancer patients, paying
special attention to the patients' quality of life. If endosseous implants
are placed in the irradiated jaw bone, a long-term follow-up is the pre-
requisite to monitor the condition of the peri-implant tissues, hereby
enabling an early detection of complications like ORN.
5 | CONCLUSIONS
Within the limitations of this study, the following conclusions can be
drawn:
1 As treatment planning differed with regard to the participants' field
of expertise and work environment, treatment of head and neck
cancer patients (condition after radiotherapy) should be centralized
to enhance the experience of the practitioners. Patients might also
benefit from a multidisciplinary structure.
2 A high agreement between the practitioners' treatment concepts
and the current state of research was observed.
3 While the choice between a mucosa- or tooth-supported, and an
implant-supported restoration depends on numerous individual fac-
tors, guidelines derived from prospective, longitudinal studies
would enhance evidence-based treatment in this field.
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